Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy and solid-organ transplantation.

Enver Akalin1, Jonathan S Bromberg

  • 1Division of Nephrology and Institute of Molecular Medicine and Gene Therapy, and Recanati-Miller Transplant Institute, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.

Kidney International
|February 14, 2002
PubMed
Summary

Gene therapy offers a promising solution to overcome major hurdles in organ transplantation, including chronic rejection and organ shortages. This review explores its potential to enhance long-term survival in transplantation medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells circumstantially initiate transplant rejection through CXCL15/neutrophil axis.

Communications biology·2026
Same author

Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same author

Fulminant Acanthamoeba Encephalitis Diagnosed By Cell-Free DNA in a Renal Transplant Patient: A Case Report.

Transplantation proceedings·2026
Same author

Qualified prediction system for allograft failure in real world settings: extended validation study.

BMJ medicine·2026
Same author

Impact of older donor age in kidney transplants in a biopsy-based observational study.

JCI insight·2026
Same author

A New Costimulatory Blockage Agent in the Pipeline.

Transplantation·2026

Area of Science:

  • Transplantation Medicine
  • Gene Therapy
  • Immunosuppression

Background:

  • Solid-organ transplantation survival has improved due to medical advancements.
  • Chronic allograft rejection and immunosuppression side effects remain significant challenges.
  • Organ donor shortage limits transplantation success.

Purpose of the Study:

  • To review the application of gene therapy in solid-organ transplantation.
  • To highlight gene therapy's potential to address transplantation obstacles.

Main Methods:

  • Literature review of studies on gene therapy in solid-organ transplantation.

Main Results:

  • Gene therapy presents unique advantages for transplantation.

Related Experiment Videos

  • Studies indicate gene therapy's potential to mitigate rejection and improve outcomes.

    • Conclusions:

    • Gene therapy is a promising approach to overcome current limitations in organ transplantation.
    • Further research and clinical application of gene therapy could significantly improve long-term transplant survival.